X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1625) 1625
Publication (159) 159
Newsletter (91) 91
Newspaper Article (58) 58
Book Review (12) 12
Transcript (12) 12
Book Chapter (8) 8
Conference Proceeding (6) 6
Magazine Article (5) 5
Reference (2) 2
Trade Publication Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
fulvestrant (1678) 1678
breast cancer (807) 807
humans (786) 786
female (735) 735
estradiol - analogs & derivatives (708) 708
oncology (642) 642
index medicus (605) 605
estradiol - pharmacology (501) 501
breast neoplasms - drug therapy (431) 431
postmenopausal women (422) 422
estrogen (418) 418
tamoxifen (398) 398
endocrine therapy (385) 385
animals (375) 375
cancer (333) 333
estrogen antagonists - pharmacology (309) 309
receptors, estrogen - metabolism (256) 256
breast neoplasms - pathology (251) 251
care and treatment (233) 233
metastasis (232) 232
breast neoplasms - metabolism (229) 229
double-blind (218) 218
anastrozole (212) 212
research (211) 211
antineoplastic agents, hormonal - therapeutic use (169) 169
estradiol - therapeutic use (167) 167
tamoxifen - pharmacology (167) 167
health aspects (161) 161
chemotherapy (159) 159
estrogen receptor (157) 157
women (157) 157
cell line, tumor (156) 156
expression (154) 154
middle aged (153) 153
therapy (150) 150
mice (146) 146
rats (144) 144
biochemistry & molecular biology (141) 141
estrogen-receptor (137) 137
endocrinology & metabolism (133) 133
tumors (133) 133
aged (132) 132
drug therapy (132) 132
estradiol (132) 132
palbociclib (131) 131
phenols (131) 131
medicine & public health (130) 130
aromatase inhibitors (129) 129
analysis (127) 127
estrogen receptors (126) 126
letrozole (124) 124
dose-response relationship, drug (123) 123
pharmacology & pharmacy (122) 122
breast neoplasms - genetics (117) 117
tumor cells, cultured (117) 117
cancer therapies (115) 115
adult (110) 110
estrogens (105) 105
gene expression (105) 105
combination (103) 103
hormones (102) 102
metastases (101) 101
article (100) 100
treatment outcome (99) 99
patients (98) 98
postmenopause (98) 98
randomized-trial (98) 98
male (97) 97
growth (96) 96
estradiol - administration & dosage (95) 95
clinical trials (94) 94
apoptosis (92) 92
oncology, experimental (92) 92
receptors, estrogen - antagonists & inhibitors (92) 92
trial (92) 92
drug resistance, neoplasm (91) 91
advanced breast cancer (90) 90
cell biology (89) 89
antineoplastic agents, hormonal - pharmacology (87) 87
estrogen receptor modulators - pharmacology (86) 86
receptors, estrogen - genetics (86) 86
gene-expression (85) 85
signal transduction (84) 84
metastatic breast cancer (82) 82
development and progression (81) 81
resistance (81) 81
cell proliferation - drug effects (80) 80
cells (80) 80
epidermal growth factor (80) 80
estrogen receptor alpha - metabolism (80) 80
erbb-2 protein (79) 79
pure antiestrogen (79) 79
breast-cancer (77) 77
antineoplastic combined chemotherapy protocols - therapeutic use (76) 76
cells, cultured (76) 76
estrogens - pharmacology (76) 76
fulvestrant 500 mg (76) 76
mcf-7 cells (76) 76
1st-line treatment (74) 74
breast (74) 74
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1758) 1758
German (12) 12
French (8) 8
Spanish (6) 6
Japanese (5) 5
Hungarian (4) 4
Chinese (1) 1
Czech (1) 1
Dutch (1) 1
Korean (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Organic Chemistry, ISSN 0022-3263, 10/2016, Volume 81, Issue 20, pp. 9630 - 9638
A series of 1,3-diphenyl-6-alkyl/arylfulvenes was prepared, and the electrochemical properties were investigated. The addition of phenyl groups about the... 
Electrochemistry | Research | Fulvestrant
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 06/2003, Volume 23, Issue 12, pp. 4984 - 4995
Estrogen influences the development and function of the nervous system through estrogen receptor-dependent changes in gene expression and by rapidly... 
fulvestrant
Journal Article
ONCOLOGIST, ISSN 1083-7159, 06/2017, Volume 22, Issue 6, pp. 755 - 755
Journal Article
The Lancet Oncology, ISSN 1470-2045, 07/2019, Volume 20, Issue 7, pp. e347 - e347
Journal Article
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, ISSN 0027-8874, 04/2019, Volume 111, Issue 4, pp. 419 - 430
Background: Palbociclib administered with endocrine therapy was tolerable when the overall incidence of toxicities was assessed separately for three PALOMA... 
WOMEN | MULTICENTER | PLACEBO | ONCOLOGY | FULVESTRANT | LETROZOLE
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2019, Volume 380, Issue 20, pp. 1929 - 1940
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2019, Volume 380, Issue 23, pp. 2282 - 2282
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer (N Engl J Med 2019;380:1226-1234). In the list of authors (page 1226), Dr.... 
Breast cancer | Metastasis | Anastrozole | Survival | Fulvestrant | Metastases
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 06/2017, Volume 23, Issue 12, pp. 3053 - 3060
Purpose: Evaluate F-18 -fluoroestradiol (FES) PET/CT as a biomarker of estrogen receptor (ER) occupancy and/or downregulation during phase I dose escalation of... 
POSITRON-EMISSION-TOMOGRAPHY | DEGRADER | ONCOLOGY | FULVESTRANT | TAMOXIFEN | METASTATIC BREAST-CANCER
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2019, Volume 380, Issue 13, pp. 1226 - 1234
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2019, Volume 37, Issue 14, pp. 1148 - 1148
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 02/2019, Volume 380, Issue 8, pp. 797 - 797
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 02/2019, Volume 380, Issue 8, pp. 796 - 796
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 04/2018, Volume 61, Issue 7, pp. 2837 - 2864
In breast cancer, estrogen receptor alpha (ERα) positive cancer accounts for approximately 74% of all diagnoses, and in these settings, it is a primary driver... 
TRIAL | AROMATASE INHIBITOR | CHEMISTRY, MEDICINAL | ACID | EFFICACY | FULVESTRANT | MODULATORS | TAMOXIFEN RESISTANCE | ALPHA | POSTMENOPAUSAL WOMEN
Journal Article
Nature Communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 1373 - 14
Using an ORF kinome screen in MCF-7 cells treated with the CDK4/6 inhibitor ribociclib plus fulvestrant, we identified FGFR1 as a mechanism of drug resistance.... 
Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Cyclin D1 - metabolism | Receptors, Estrogen - metabolism | Circulating Tumor DNA - genetics | Humans | Purines - administration & dosage | Fulvestrant - pharmacology | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Quinolines - pharmacology | Breast Neoplasms - metabolism | Quinoxalines - pharmacology | MCF-7 Cells | Fulvestrant - administration & dosage | Female | Receptor, Fibroblast Growth Factor, Type 2 - antagonists & inhibitors | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Pyrazoles - pharmacology | Aminopyridines - administration & dosage | Antineoplastic Agents, Hormonal - pharmacology | Signal Transduction | Purines - pharmacology | Antineoplastic Agents, Hormonal - administration & dosage | Proportional Hazards Models | Breast Neoplasms - drug therapy | Piperazines - pharmacology | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Naphthalenes - pharmacology | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aminopyridines - pharmacology | Progression-Free Survival | High-Throughput Nucleotide Sequencing | Mice | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Mutation | Receptor, Fibroblast Growth Factor, Type 2 - genetics | Drug Resistance, Neoplasm - drug effects | Tyrosine | Xenotransplantation | Clinical trials | Antagonists | Breast cancer | Drug resistance | Patients | Cyclin-dependent kinase 4 | Fulvestrant | Gene sequencing | Amplification | Next-generation sequencing | Inhibitors | Xenografts | Breast | Open reading frames | Fibroblast growth factor receptor 1 | Protein-tyrosine kinase | Deoxyribonucleic acid--DNA | DNA sequencing | Cancer | Fibroblast growth factor receptors
Journal Article
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 06/2019, Volume 16, Issue 6, pp. 337 - 337
Journal Article
Cancer discovery, ISSN 2159-8274, 3/2017, Volume 7, Issue 3, pp. 277 - 287
Recent studies have identified somatic ESR1 mutations in patients with metastatic breast cancer (MBC) and found some of them to promote estrogen-independent... 
AZD9496 | breast cancer | estrogen | ESR1 | fulvestrant
Journal Article
European Journal of Cancer Care, ISSN 0961-5423, 03/2018, Volume 27, Issue 2, pp. e12834 - n/a
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.